Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 16, 2012

View Archived Issues

Phase III trial compares antibiotics in children with neglected tropical disease

Study links gene's methylation status to response of colorectal cancer to chemotherapy

Sustained T-cell responses obtained with HCV vaccine based on rare adenoviral vectors

Novel dual specificity protein kinase TTK inhibitors reported

XiberScience identifies new RhoA-inhibiting peptides

Novel PET imaging agent described for use in breast cancer diagnosis

Medivir designs new cathepsin S inhibitors

Stem Cell Educator therapy evaluated in patients with type 1 diabetes

Chinese company patents novel PPAR agonists

Pfizer presents new glucokinase activators

Otsuka Pharmaceutical and UCB adjust focus of collaboration

Otsuka Pharmaceutical files NDA in Japan

First study site chosen for pivotal phase II/III trial in hemophilia

Treatment begins in phase II study of Advaxis' ADXS-HPV

Spherix completes SPX-106 toxicology study for IND submission

Fifth Merrimack Pharmaceuticals program advances to clinic

World's first hepatitis E vaccine approved in China

Fostoin set for launch in Japan

Health Canada grants priority review status to Cinryze

Phytopharm reports preclinical data on Cogane in ALS

Astex Pharmaceuticals transfers results of epigenetics project to GSK

Nuron Biotech licenses flu vaccine to Mitsubishi Tanabe Pharma for Japan

Photocure completes enrollment in phase IIb trial of Visonac

Sobi signs licensing agreement for therapy for neonates with diuresis and seizures

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...